Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Yang

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Cancer Discovery|May 30, 2023
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical DevelopmentMichael J Dickinson, Pere Barba, Ulrich Jäger, et al.
NPJ Vaccines|January 9, 2025
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infectionJun Liu, Li Wang, Alexandra Kurtesi, et al.
Nature Communications|April 15, 2020
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathwayGregory M LaMonte, Frances Rocamora, Danushka S Marapana, et al.
Molecular Cancer Therapeutics|March 26, 2017
Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family InhibitorTimothy P S Perera, Eleonora Jovcheva, Laurence Mevellec, et al.
Communications Biology|February 12, 2022
Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistanceSabine Ottilie, Madeline R Luth, Erich Hellemann, et al.
Cancer Research|December 19, 2024
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal CancerJeremy B Foote, Tyler E Mattox, Adam B Keeton, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI CancerJeremy B Foote, Tyler E Mattox, Adam B Keeton, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Cancer Discovery|May 30, 2023
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical DevelopmentMichael J Dickinson, Pere Barba, Ulrich Jäger, et al.
NPJ Vaccines|January 9, 2025
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infectionJun Liu, Li Wang, Alexandra Kurtesi, et al.
Nature Communications|April 15, 2020
Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathwayGregory M LaMonte, Frances Rocamora, Danushka S Marapana, et al.
Molecular Cancer Therapeutics|March 26, 2017
Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family InhibitorTimothy P S Perera, Eleonora Jovcheva, Laurence Mevellec, et al.
Communications Biology|February 12, 2022
Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistanceSabine Ottilie, Madeline R Luth, Erich Hellemann, et al.
Cancer Research|December 19, 2024
A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal CancerJeremy B Foote, Tyler E Mattox, Adam B Keeton, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI CancerJeremy B Foote, Tyler E Mattox, Adam B Keeton, et al.
Pageof 9